Please use this identifier to cite or link to this item:
http://sgc.anlis.gob.ar/handle/123456789/1614| Title: | Coronavirus: cinco claves del suero hiperinmune de caballo que se probará en humanos | Keywords: | COVID19;Medios de Comunicación;Suero Terapéutico COVID19 | Issue Date: | 18-Jun-2020 | Publisher: | TN | Abstract: | Sería una alternativa de inmunización pasiva más efectiva para atenuar los efectos del COVID-19 a corto y mediano plazo. Esperan la aprobación de la ANMAT. |
URI: | https://tn.com.ar/salud/lo-ultimo/coronavirus-cinco-claves-del-suero-hiperinmune-de-caballo-que-se-probara-en-humanos_1083591 http://sgc.anlis.gob.ar/handle/123456789/1614 |
| Appears in Collections: | ANLIS frente a la epidemia COVID-19 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Coronavirus cinco claves del suero hiperinmune de caballo que será probado en humanos.pdf | 422.39 kB | Adobe PDF |  View/Open |
Page view(s)
65
checked on Apr 26, 2024
Download(s)
4
checked on Apr 26, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.